New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
OTCTranslated

TRIFER

100MG DE FER ELEMENTAIRE/5ML/Oral Solution/HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE
ABDI IBRAHIM OTSUKA
ManufacturerVerified lab

ABDI IBRAHIM OTSUKA

Public retail price
320.00DZD
Reference price (TR): 223.00 DZD

Identification

Active ingredient (INN)
HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE
Internal code
12 E 106
Country of Origin
Algeria
Pharmaceutical form
Oral Solution
Prescription List
OTC
Packaging
b/10fl. de 5ml
TRIFER
Clinical View

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

Questions or

Comments? Call 800.570.0021 Between 9am-5pm PST info@siddhaflowers.com siddhaflowers.com MFD by Siddha Flower Essences Oxnard, CA 93030 Made in USA.

Indications

Uses temporarily relieves symptoms of critical and intolerant quarrelsome irritable, especially in mornings hurried and anxious quick to react indications are based on homeopathic materia medica, not clinical tests.

Associated Conditions

Lactation Asthma Folic acid deficiency Immune deficiency Child under 15 years of age Inflammatory Pregnancy Infection Hepatic impairment Dialysis patient Patients previously treated with oral therapy Patient subject to autologous sampling High dose treated patient Late skin porphyria Subject at risk of phosphorous depletion Allergic field Extended treatment Repeated treatment.

Mechanism of Action

Mechanism of action

Iron is an essential component of the body.

It is necessary for the formation of hemoglobin and the oxidation processes of living tissues.

Ferrous fumarate contains 33% iron metal.

Ferrous salts are generally poorly absorbed (10-20% of the ingested dose).

This absorption is increased when iron reserves are reduced.

Absorption occurs mainly at the level of the duodenum and the proximal part of the jejunum.

The iron hydroxide-saccharose complex in solution allows iron to be fed by the intravenous route.

The stable complex of ferric hydroxide and dextran is similar to the physiological form of iron: ferritin (ferric hydroxide complex and phosphate protein) In imaging, as non-stoichiometric magnetite particles silylated, iron is a contrast product for MRI.

Adverse Effects

  • (increase) (Uncommon)
  • Hypophosphataemia (Uncommon)
  • Liver enzymes (increase) (Uncommon)
  • Ferritine (increase) (Uncommon)
  • ASAT (increase) (Uncommon)
  • Gamma GT (increase) (Uncommon)
  • LDH (increase) (Rare)
  • Urticaria (Uncommon)
  • Dermatitis (Uncommon)
  • Pruritus (Uncommon)
  • Skin exfoliation (Uncommon)
  • Rash (Common)
  • Hypersudation (Uncommon)
  • Exanthema (Uncommon)
  • Facial Erythema (Uncommon)
  • Hyperhidrosis (Rare)
  • Palor Skin colour impairment Abnormal colouration at the injection site
  • Chest suppression (Common)
  • Pain (Uncommon)
  • Peripheral edema (Uncommon)
  • Frisher (Uncommon)
  • Chest pain (Uncommon)
  • Fever (Uncommon)
  • Pain in limbs (Uncommon)
  • Asthenia (Uncommon)
  • Fatigue (Uncommon)
  • Burning sensation (Uncommon)
  • Irflu pseudo-influenza syndrome (Rare)
  • Edema Deaths Cold sweat Fishbane reaction Hematoma Hypersensitivity (Uncommon)
  • Angioedema (Rare)
  • Anaphylactic reaction (Rare)
  • Anaphylactoid reaction (Rare)
  • Oedema of Quincke Delayed hypersensitivity
  • Immediate hypersensitivity Infection (Uncommon)
  • Phlebitis at the injection site (Uncommon)
  • Infusion site reaction (Common)
  • Injection site reaction (Common)
  • Hematoma at the injection site
  • Discoloration at the injection site Swelling at the injection site Erythema at the injection site
  • Thrombophlebitis at the injection site Extravasation at the injection site Injection site edema
  • Pruritus at the injection site Irritation at the injection site Injection site bruising
  • Infusion site pain Pain at injection site Burning sensation at the injection site
  • Fetal Bradycardia Blurty vision (Uncommon)
  • Vertigo (Uncommon)
  • Dysgueusia (Common)
  • Dysphony (Rare)
  • Metallic taste Mental confusion Anxiety Congestive puff (Uncommon)
  • Hypertension (Common)
  • Hot flash (Uncommon)
  • Tachycardia (Uncommon)
  • Hypotension (Common)
  • Phlebitis (Uncommon)
  • Syncope (Rare)
  • Malaise (Rare)
  • Arrhythmia (Rare)
  • Palpitation (Rare)
  • Cardiovascular collapsus Bradycardia Kounis syndrome Thrombophlebitis Constipation (Uncommon)
  • Vomiting (Uncommon)
  • Dyspepsia (Uncommon)
  • Nausea (Common)
  • Abdominal pain (Uncommon)
  • Diarrhoea (Uncommon)
  • Joint pain (Uncommon)
  • Joint swelling (Common)
  • Sleeping (Uncommon)
  • Musculoskeletal scarring (Uncommon)
  • Muscle pain (Uncommon)
  • Muscle spasm (Uncommon)
  • Cramp (Rare)
  • Bone pain (Rare)
  • Arthritis (Rare)
  • Loss of consciousness (Uncommon)
  • Paraesthesia (Uncommon)
  • Headache (Uncommon)
  • Trembling (Uncommon)
  • Hypoesthesia (Uncommon)
  • Mental damage (Rare)
  • Convulsions (Rare)
  • Somnolence (Rare)
  • Epilepsy (crisis)
  • Alteration of consciousness
  • Dyspnoea (Uncommon)
  • Bronchospasm (Uncommon)
  • Difficulty breathing Urine colour (change) (Rare).

Warnings

Uses Stop use and ask a doctor if symptoms persist or worsen If pregnant or breast-feeding ask a health professional before use Keep out of reach of children.

Dosage & Administration

Directions best if used in the morning and just before bed use 5 days per week until symptoms are relieved adults and children 12 years and over 4-5 sprays in mouth twice per day children 2 years to under 12 years 2-3 sprays in mouth twice per day children under 2 years consult a doctor.

Storage & Handling

Information do not use if plastic seal around cap is broken or missing. store in a cool, dry place.

Alternatives